Key Insights

Highlights

Success Rate

94% trial completion (above average)

Clinical Risk Assessment

Based on trial outcomes

Moderate Risk

Score: 40/100

Termination Rate

3.1%

2 terminated out of 64 trials

Success Rate

94.1%

+7.5% vs benchmark

Late-Stage Pipeline

13%

8 trials in Phase 3/4

Results Transparency

28%

9 of 32 completed with results

Key Signals

9 with results94% success

Data Visualizations

Phase Distribution

30Total
Not Applicable (17)
P 1 (3)
P 2 (2)
P 3 (5)
P 4 (3)

Trial Status

Completed32
Active Not Recruiting10
Recruiting9
Not Yet Recruiting6
Enrolling By Invitation3
Unknown2

Trial Success Rate

94.1%

Benchmark: 86.6%

Based on 32 completed trials

Clinical Trials (64)

Showing 20 of 20 trials
NCT07855458Not Yet RecruitingPrimary

ESA Hyporesponsiveness in Hemodialysis Patients

NCT07781371Active Not Recruiting

A Retrospective Real-World Cohort Study

NCT05106387RecruitingPrimary

An Observational Extension Study for Adult Patients Treated in Study R5459-RT-1944 Who Receive a Kidney Transplant

NCT06383390Phase 3Active Not Recruiting

The Effect of Retatrutide Once Weekly on Cardiovascular Outcomes and Kidney Outcomes in Adults Living With Obesity (TRIUMPH-Outcomes)

NCT07193056Recruiting

The CPH-MBD Cohort

NCT07382960Active Not Recruiting

Pramipexole and the Risk of Serious Adverse Events

NCT07387120Active Not RecruitingPrimary

Sertraline and the Risk of Serious Adverse Events

NCT07179978Active Not RecruitingPrimary

Lorazepam and the Risk of Serious Adverse Events

NCT07274241Active Not RecruitingPrimary

Escitalopram and the Risk of Serious Adverse Events

NCT07399795Active Not RecruitingPrimary

Citalopram and the Risk of Serious Adverse Events

NCT07098078Active Not RecruitingPrimary

Domperidone and the Risk of Serious Adverse Events

NCT07274228Active Not RecruitingPrimary

Tamsulosin and the Risk of Serious Adverse Events

NCT07808944CompletedPrimary

Trace Element Imbalances in Dialysis Patients With CKD: the Role of Hemodialysis

NCT07781124Recruiting

Clinical Effectiveness and Resource Use in End-Stage Renal Disease Patients: Remote Patient Monitoring Across Dialysis Modalities

NCT07763483Not Yet RecruitingPrimary

Do Endocrine Disruptors Accumulate in Children Undergoing Paediatric Dialysis?

NCT07023016Phase 2Completed

Comparative Assessment of Efficacy & Safety of Sacubitril/Valsartan Versus Ramipril in Patients With Renal Dysfunction Hospitalized With Acute Decompensated Heart Failure

NCT07746037Not ApplicableNot Yet RecruitingPrimary

Assessment of Dietary Balance in Home-Dwelling Patients With Stage 4 and 5 Chronic Kidney Disease Using URIKI (IKI), a Connected Urine Test Strip and In Vitro Diagnostic Medical Device

NCT07391904Not ApplicableEnrolling By InvitationPrimary

Patient-centered Precision Medicine Lab Result Communication for Older Adults

NCT07701382Not ApplicableNot Yet RecruitingPrimary

Remote vs In-Person Prehabilitation for Kidney Transplant Candidates

NCT07660757Completed

Epidemiological Cluster Evaluation in Patients Admitted to Internal Medicine, With at Least One of the Following Diagnoses: Heart Failure, COPD, Renal Failure. The FADOI IN-CluDiMI Study

Scroll to load more

Research Network

Activity Timeline